Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AXYS Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (264)	5/13/1999 4:36:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 455

Bob: I don't own it any longer. Not certain how long I held those shares. I can look at my 1040 to see, if anyone cares. However, I have been watching it, trying to decide if it is worth some weighting relative largely to a bunch of neuro stuff. First.... John Dwyer follows the company more closely than I do. I like Mike Venuti. They have a license from Chiron to use the HCV protease as a target, and Chiron is taking everyone else to court. Rick

To: RCMac who wrote (264)	5/13/1999 4:52:00 PM
From: scaram(o)uche	Respond to of 455

regarding the Boehringer Mannheim project, it'll be fun to watch for this....... biz.yahoo.com or maybe not so much fun.

To: RCMac who wrote (264)	5/13/1999 5:35:00 PM
From: LLCF	Respond to of 455

< big pharmas' judgment is hardly faultless, but when a bunch of them vote the same way with big money, I pay attention.> Yes certainly worth paying attention... I'm interested in AXPH because there are so many positive things going on and yet so cheap. Seemingly only because they are so early stage and no exciting trials to watch near term. Yet if you're looking past revenues, past (near term) pipeline, you'd love it. Clearly the market has gotten past revenues to pipeline (finally) and when that starts getting long in the tooth (or before?) just maybe.........? we'll see. In addition who knows what they discover stumbling around in their pre-clinic. Certainly seems to be one to sock away for the kids or whatever. Thanks so much for you're summary, very informative. DAK